Identification of molecular markers for articular cartilage

Osteoarthritis and Cartilage

Volumn 18, Issue 12, 2010, Pages 1630-1638

  Hissnauer, T N ^a   Baranowsky, A ^a   Pestka, J M ^a   Streichert, T ^a   Wiegandt, K ^b   Goepfert, C ^b   Beil, F T ^a   Albers, J ^a   Schulze, J ^a   Ueblacker, P ^a,c   Petersen, J P ^a   Schinke, T ^a   Meenen, N M ^d   Portner R ^b   Amling, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^c MW Centre for Orthopaedics and Sports Medicine   (Germany)

^d Altonaer Kinderkrankenhaus   (Germany)

Author keywords

Cartilage; Molecular markers; Osteoarthritis; Tissue engineered

Indexed keywords

MOLECULAR MARKER; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GROWTH PLATE; KNEE; MINIPIG; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE ENGINEERING;

ANIMALS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CHONDROCYTES; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GROWTH PLATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; SWINE, MINIATURE; TISSUE ENGINEERING;

EID: 78649702883     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.10.002     Document Type: Article

References (32)

1. Helmick C.G., Felson D.T., Lawrence R.C., Gabriel S., Hirsch R., Kwoh C.K., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008, 5:15-25.
2. Chiang H., Jiang C.C. Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc 2009, 108:87-101.
3. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895.
4. Bentley G., Biant L.C., Carrington R.W., Akmal M., Goldberg A., Williams A.M., et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br 2003, 85:223-230.
5. Erggelet C., Sittinger M., Lahm A. The arthroscopic implantation of autologous chondrocytes for the treatment of full-thickness cartilage defects of the knee joint. Arthroscopy 2003, 19:108-110.
6. Niemeyer P., Pestka J.M., Kreuz P.C., Erggelet C., Schmal H., Suedkamp N.P., et al. Characteristic complications after autologous chondrocyte implantation for cartilage defects of the knee joint. Am J Sports Med 2008, 36:2091-2099.
7. Roberts S., McCall I.W., Darby A.J., Menage J., Evans H., Harrison P.E., et al. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res Ther 2003, 5:R60-R73.
8. Kreuz P.C., Steinwachs M., Erggelet C., Lahm A., Henle P., Niemeyer P. Mosaicplasty with autogenous talar autograft for osteochondral lesions of the talus after failed primary arthroscopic management: a prospective study with a 4-year follow-up. Am J Sports Med 2006, 34:55-63.
9. Hangody L., Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am 2003, 85-A(Suppl 2):25-32.
10. Mithoefer K., Hambly K., Della Villa S., Silvers H., Mandelbaum B.R. Return to sports participation after articular cartilage repair in the knee: scientific evidence. Am J Sports Med 2009, 37(Suppl 1):167S-176S.
11. Petersen J.P., Ueblacker P., Goepfert C., Adamietz P., Baumbach K., Stork A., et al. Long term results after implantation of tissue engineered cartilage for the treatment of osteochondral lesions in a minipig model. J Mater Sci Mater Med 2008, 19:2029-2038.
12. Nagel-Heyer S., Goepfert C., Morlock M.M., Portner R. Relationship between physical, biochemical and biomechanical properties of tissue-engineered cartilage-carrier-constructs. Biotechnol Lett 2005, 27:187-192.
13. Nagel-Heyer S., Goepfert C., Feyerabend F., Petersen J.P., Adamietz P., Meenen N.M., et al. Bioreactor cultivation of three-dimensional cartilage-carrier-constructs. Bioprocess Biosyst Eng 2005, 27:273-280.
14. Martin I., Vunjak-Novakovic G., Yang J., Langer R., Freed L.E. Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res 1999, 253:681-688.
15. Buschmann M.D., Gluzband Y.A., Grodzinsky A.J., Kimura J.H., Hunziker E.B. Chondrocytes in agarose culture synthesize a mechanically functional extracellular matrix. J Orthop Res 1992, 10:745-758.
16. Korhonen R.K., Laasanen M.S., Toyras J., Rieppo J., Hirvonen J., Helminen H.J., et al. Comparison of the equilibrium response of articular cartilage in unconfined compression, confined compression and indentation. J Biomech 2002, 35:903-909.
17. Settle S.H., Rountree R.B., Sinha A., Thacker A., Higgins K., Kingsley D.M. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 2003, 254:116-130.
18. Dell'Accio F., De Bari C., Luyten F.P. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum 2001, 44:1608-1619.
19. Benz K., Breit S., Lukoschek M., Mau H., Richter W. Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem Biophys Res Commun 2002, 293:284-292.
20. Grogan S.P., Barbero A., Diaz-Romero J., Cleton-Jansen A.M., Soeder S., Whiteside R., et al. Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum 2007, 56:586-595.
21. Yamane S., Cheng E., You Z., Reddi A.H. Gene expression profiling of mouse articular and growth plate cartilage. Tissue Eng 2007, 13:2163-2173.
22. Schumacher B.L., Block J.A., Schmid T.M., Aydelotte M.B., Kuettner K.E. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys 1994, 311:144-152.
23. Latini F.R., Hemerly J.P., Oler G., Riggins G.J., Cerutti J.M. Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocr Relat Cancer 2008, 15:787-799.
24. Martin J.A., Buckwalter J.A. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am 2003, 85-A(Suppl 2):106-110.
25. Price J.S., Waters J.G., Darrah C., Pennington C., Edwards D.R., Donell S.T., et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002, 1:57-65.
26. Oliver G., Wehr R., Jenkins N.A., Copeland N.G., Cheyette B.N., Hartenstein V., et al. Homeobox genes and connective tissue patterning. Development 1995, 121:693-705.
27. Ruf R.G., Xu P.X., Silvius D., Otto E.A., Beekmann F., Muerb U.T., et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004, 101:8090-8095.
28. Ou Z., Martin D.M., Bedoyan J.K., Cooper M.L., Chinault A.C., Stankiewicz P., et al. Branchiootorenal syndrome and oculoauriculovertebral spectrum features associated with duplication of SIX1, SIX6, and OTX2 resulting from a complex chromosomal rearrangement. Am J Med Genet A 2008, 146A:2480-2489.
29. Ozaki H., Nakamura K., Funahashi J., Ikeda K., Yamada G., Tokano H., et al. Six1 controls patterning of the mouse otic vesicle. Development 2004, 131:551-562.
30. Agah A., Kyriakides T.R., Lawler J., Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002, 161:831-839.
31. Bornstein P., Agah A., Kyriakides T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol 2004, 36:1115-1125.
32. Pietschmann M.F., Horng A., Niethammer T., Pagenstert I., Sievers B., Jansson V., et al. Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee. Knee Surg Sports Traumatol Arthrosc 2009, 17:1305-1311.